Juliana Estevez
Primary Care · Tampa, FLNPI 1124517024
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 330 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Tris Pharma Inc$944
- Corium, LLC$701
- Supernus Pharmaceuticals, Inc.$488
- Jazz Pharmaceuticals Inc.$457
- Neurelis, Inc.$451
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,471100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 54 | $1,135 |
| Tris Pharma Inc | 51 | $944 |
| Corium, LLC | 28 | $701 |
| Supernus Pharmaceuticals, Inc. | 46 | $488 |
| Jazz Pharmaceuticals Inc. | 20 | $457 |
| Neurelis, Inc. | 24 | $451 |
| Aquestive Therapeutics, Inc. | 16 | $340 |
| Ironshore Pharmaceuticals Inc. | 13 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $195 |
| Livanova USA, Inc. | 2 | $152 |
| Noven Therapeutics, LLC | 7 | $135 |
| Sunovion Pharmaceuticals Inc. | 7 | $127 |
| Immedica Pharma US, Inc. | 5 | $116 |
| Acadia Pharmaceuticals Inc | 5 | $115 |
| Teva Pharmaceuticals USA, Inc. | 2 | $113 |
| SK Life Science, Inc. | 3 | $86 |
| Biomarin Pharmaceutical Inc. | 4 | $71 |
| Biogen | 3 | $64 |
| Zogenix Inc. | 3 | $63 |
| Upsher-smith Laboratories LLC | 2 | $60 |
| Eisai Inc. | 3 | $59 |
| Amneal Pharmaceuticals LLC | 3 | $56 |
| Neos Therapeutics, LP | 3 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Mirum Pharmaceuticals, Inc. | 2 | $37 |
| Otter Pharmaceuticals, LLC | 1 | $29 |
| PTC Therapeutics, Inc. | 2 | $29 |
| Biocodex, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Novartis | 1 | $14 |
| Aucta Pharmaceuticals, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Quillivant$270
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$131
- Quillichew ER$122
- Dyanavel XR$122
- Azstarys$115
- Onyda XR$100
How this compares
$6,471 in reported general payments places this provider in the 95th percentile of 725 primary care providers in Florida.
Other primary care in Tampa
- Elisa TurkoTampa$5K
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.